SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-007925
Filing Date
2019-05-07
Accepted
2019-05-07 07:01:19
Documents
52
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0319_intecpharma.htm 10-Q 447886
2 CERTIFICATION f10q0319ex31-1_intec.htm EX-31.1 14912
3 CERTIFICATION f10q0319ex31-2_intec.htm EX-31.2 14334
4 CERTIFICATION f10q0319ex32-1_intec.htm EX-32.1 5004
5 CERTIFICATION f10q0319ex32-2_intec.htm EX-32.2 5016
6 GRAPHIC img_001.jpg GRAPHIC 1750
  Complete submission text file 0001213900-19-007925.txt   2197658

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ntec-20190331.xml EX-101.INS 327797
8 XBRL SCHEMA FILE ntec-20190331.xsd EX-101.SCH 38481
9 XBRL CALCULATION FILE ntec-20190331_cal.xml EX-101.CAL 40022
10 XBRL DEFINITION FILE ntec-20190331_def.xml EX-101.DEF 82545
11 XBRL LABEL FILE ntec-20190331_lab.xml EX-101.LAB 205589
12 XBRL PRESENTATION FILE ntec-20190331_pre.xml EX-101.PRE 149103
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37521 | Film No.: 19801167
SIC: 2834 Pharmaceutical Preparations